Bradykinesia in patients with Parkinson's disease having levodopa-induced dyskinesias
暂无分享,去创建一个
Christian Duval | Roderick Edwards | Mandar Jog | M. Jog | C. Duval | R. Edwards | Sarah Lemieux | M. Ghassemi | Mehrdad Ghassemi | Sarah Lemieux
[1] A. Beuter,et al. Analysis of rapid alternating movements in Cree subjects exposed to methylmercury and in subjects with neurological deficits. , 1999, Environmental research.
[2] A Schrag,et al. The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.
[3] C. F. Snyder,et al. Evaluation of a measurement strategy for Parkinson's disease: Assessing patient health-related quality of life , 2000, Quality of Life Research.
[4] T. Paolo,et al. Chronic treatment withl-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding , 1986, Brain Research.
[5] Andreas Daffertshofer,et al. A dynamical model for mirror movements , 1999 .
[6] M. Hallett,et al. Pathophysiology of bradykinesia in Parkinson's disease. , 2001, Brain : a journal of neurology.
[7] J. Nutt,et al. Motor fluctuations and dyskinesia in Parkinson's disease. , 2001, Parkinsonism & related disorders.
[8] J. Larsen,et al. Health related quality of life in Parkinson's disease: a prospective longitudinal study , 2000, Journal of neurology, neurosurgery, and psychiatry.
[9] H. Glick,et al. Preference-based quality-of-life in patients with Parkinson’s disease , 2002, Neurology.
[10] J. Nutt. Fluctuations in response to treatment for Parkinson's disease. , 2001, Advances in neurology.
[11] E. Melamed. Early-morning dystonia. A late side effect of long-term levodopa therapy in Parkinson's disease. , 1979, Archives of neurology.
[12] J L Vitek,et al. Physiology of hypokinetic and hyperkinetic movement disorders: model for dyskinesia. , 2000, Annals of neurology.
[13] M. Merello,et al. Sleep benefit in parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.
[14] M. Piercey,et al. Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys. , 1995, The Journal of pharmacology and experimental therapeutics.
[15] Neither simple nor sequential arm movements are bradykinetic in parkinsonian patients with peak-dose dyskinesias , 2005, Clinical Neurophysiology.
[16] M. Muenter,et al. Patterns of dystonia ("I-D-I" and "D-I-D-") in response to l-dopa therapy for Parkinson's disease. , 1977, Mayo Clinic proceedings.
[17] D J Brooks,et al. Neuroimaging of dyskinesia. , 2000, Annals of neurology.
[18] G. Naglie,et al. Quality of life in early Parkinson's disease: Impact of dyskinesias and motor fluctuations , 2004, Movement disorders : official journal of the Movement Disorder Society.
[19] J L Bradshaw,et al. Mirror movements in normal adult subjects. , 1994, Journal of clinical and experimental neuropsychology.
[20] W R Woodward,et al. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. , 1984, The New England journal of medicine.
[21] A. E. Lang,et al. Identification and characterization of neurons with tremor-frequency activity in human globus pallidus , 1997, Experimental Brain Research.
[22] Joseph Jankovic,et al. Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations , 2005, Movement disorders : official journal of the Movement Disorder Society.
[23] Abbas F. Sadikot,et al. The impact of ventrolateral thalamotomy on tremor and voluntary motor behavior in patients with Parkinson’s disease , 2006, Experimental Brain Research.
[24] M. Delong,et al. Functional and pathophysiological models of the basal ganglia , 1996, Current Opinion in Neurobiology.
[25] M. Vidailhet,et al. Worsening of levodopa‐induced dyskinesias by motor and mental tasks , 1999, Movement disorders : official journal of the Movement Disorder Society.
[26] C. Goetz,et al. Levodopa-induced myoclonus. , 1975, Archives of neurology.
[27] P. Beek,et al. Coordination disorders in patients with Parkinson's disease: a study of paced rhythmic forearm movements , 2000, Experimental Brain Research.
[28] R. Wenzelburger. Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease? , 2005, Clinical Neurophysiology.
[29] M Okada. A method for quantification of alternate pronation and supination of forearms. , 1983, Computers and biomedical research, an international journal.
[30] Laurent Gerbaud,et al. Impact of the motor complications of Parkinson's disease on the quality of life , 2005, Movement disorders : official journal of the Movement Disorder Society.
[31] J G Nutt,et al. Levodopa‐induced dyskinesia , 1990, Neurology.
[32] Y. Agid,et al. Pathophysiology of L-dopa-induced abnormal involuntary movements. , 1985, Psychopharmacology. Supplementum.
[33] R. Camicioli,et al. Adverse Reactions to Controlled Release Levodopa/Carbidopa in Older Persons: Case Reports , 1995, Journal of the American Geriatrics Society.
[34] Christine A. Armatas,et al. Handedness and performance variability as factors influencing mirror movement occurrence. , 1996, Journal of clinical and experimental neuropsychology.
[35] U Sabatini,et al. Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia. , 1998, Brain : a journal of neurology.
[36] A. Sadikot,et al. The relationship between physiological tremor and the performance of rapid alternating movements in healthy elderly subjects , 2001, Experimental Brain Research.
[37] Bernard R. Rosner,et al. Fundamentals of Biostatistics. , 1992 .
[38] M. Caligiuri,et al. A quantitative study of levodopa-induced dyskinesia in Parkinson's disease , 1993, Journal of neural transmission. Parkinson's disease and dementia section.